Feb 25, 2021 / 01:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Adaptimmune conference call. With that, I'd like to turn the call over to Juli Miller. Ma'am, you may begin.
Juli P. Miller - Adaptimmune Therapeutics plc - Senior Director of IR
Good morning, and welcome to Adaptimmune's conference call to discuss our full year and fourth quarter 2020 financial results and business update. I would ask you to please review the full text of our forward-looking statements from this morning's press release. We anticipate making projections during this call and actual results could differ materially due to a number of factors, including those outlined in our latest filings with the SEC.
Adrian Rawcliffe, our Chief Executive Officer, is with me for the prepared portion of this call. Other members of our management team will be available for Q&A.
With that, I'll turn the call over to Adrian. Ad?
Adrian G. Rawcliffe - Adaptimmune Therapeutics plc - CEO, Principal Accounting Officer & Director
Q4 2020 Adaptimmune Therapeutics PLC Earnings Call Transcript
Feb 25, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers